These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 23971123)
1. Risk of nevirapine-associated Stevens-Johnson syndrome among HIV-infected pregnant women: the Medunsa National Pharmacovigilance Centre, 2007 - 2012. Dube N; Adewusi E; Summers R S Afr Med J; 2013 May; 103(5):322-5. PubMed ID: 23971123 [TBL] [Abstract][Full Text] [Related]
2. Stevens-Johnson syndrome associated with nevirapine use in an HIV-positive pregnant woman: a case report. Agboghoroma CO; Uwaezuoke T; Jibrin PG West Afr J Med; 2010; 29(3):187-9. PubMed ID: 20665464 [TBL] [Abstract][Full Text] [Related]
3. Nevirapine toxicity in a cohort of HIV-1-infected pregnant women. João EC; Calvet GA; Menezes JA; D'Ippolito MM; Cruz ML; Salgado LA; Matos HJ Am J Obstet Gynecol; 2006 Jan; 194(1):199-202. PubMed ID: 16389032 [TBL] [Abstract][Full Text] [Related]
4. Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. Fagot JP; Mockenhaupt M; Bouwes-Bavinck JN; Naldi L; Viboud C; Roujeau JC; AIDS; 2001 Sep; 15(14):1843-8. PubMed ID: 11579247 [TBL] [Abstract][Full Text] [Related]
5. Stevens Johnson Syndrome and Toxic Epidermal Necrolysis: Maternal and Foetal Outcomes in Twenty-Two Consecutive Pregnant HIV Infected Women. Knight L; Todd G; Muloiwa R; Matjila M; Lehloenya RJ PLoS One; 2015; 10(8):e0135501. PubMed ID: 26267659 [TBL] [Abstract][Full Text] [Related]
6. Stevens-Johnson syndrome and HIV in children in Swaziland. Dziuban EJ; Hughey AB; Stewart DA; Blank DA; Kochelani D; Draper HR; Schutze GE Pediatr Infect Dis J; 2013 Dec; 32(12):1354-8. PubMed ID: 23743542 [TBL] [Abstract][Full Text] [Related]
7. Stevens-Johnson syndrome in an HIV-infected patient. Blitz M; Spivack E; Kerpel SM; Freedman PD AIDS Read; 1999; 9(3):184-5, 190. PubMed ID: 12728904 [TBL] [Abstract][Full Text] [Related]
8. Severe antiretroviral-associated skin reactions in South African patients: a case series and case-control analysis. Stewart A; Lehloenya R; Boulle A; de Waal R; Maartens G; Cohen K Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1313-1319. PubMed ID: 27464823 [TBL] [Abstract][Full Text] [Related]
9. Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretrovirals. Ouyang DW; Brogly SB; Lu M; Shapiro DE; Hershow RC; French AL; Leighty RM; Thompson B; Tuomala RE AIDS; 2010 Jan; 24(1):109-14. PubMed ID: 19926957 [TBL] [Abstract][Full Text] [Related]
10. Adverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medication. Aaron E; Kempf MC; Criniti S; Tedaldi E; Gracely E; Warriner A; Kumar R; Bachmann LH PLoS One; 2010 Sep; 5(9):e12617. PubMed ID: 20838641 [TBL] [Abstract][Full Text] [Related]
11. Impact of glutathione transferases genes polymorphisms in nevirapine adverse reactions: a possible role for GSTM1 in SJS/TEN susceptibility. Ciccacci C; Latini A; Politi C; Mancinelli S; Marazzi MC; Novelli G; Palombi L; Borgiani P Eur J Clin Pharmacol; 2017 Oct; 73(10):1253-1259. PubMed ID: 28689274 [TBL] [Abstract][Full Text] [Related]
12. Stevens-Johnson syndrome caused by the antiretroviral drug nevirapine. Metry DW; Lahart CJ; Farmer KL; Hebert AA J Am Acad Dermatol; 2001 Feb; 44(2 Suppl):354-7. PubMed ID: 11174414 [TBL] [Abstract][Full Text] [Related]
13. Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022. Hitti J; Frenkel LM; Stek AM; Nachman SA; Baker D; Gonzalez-Garcia A; Provisor A; Thorpe EM; Paul ME; Foca M; Gandia J; Huang S; Wei LJ; Stevens LM; Watts DH; McNamara J; J Acquir Immune Defic Syndr; 2004 Jul; 36(3):772-6. PubMed ID: 15213559 [TBL] [Abstract][Full Text] [Related]
14. A multivariate genetic analysis confirms rs5010528 in the human leucocyte antigen-C locus as a significant contributor to Stevens-Johnson syndrome/toxic epidermal necrolysis susceptibility in a Mozambique HIV population treated with nevirapine. Ciccacci C; Politi C; Mancinelli S; Ciccacci F; Lucaroni F; Novelli G; Marazzi MC; Palombi L; Borgiani P J Antimicrob Chemother; 2018 Aug; 73(8):2137-2140. PubMed ID: 29762688 [TBL] [Abstract][Full Text] [Related]
15. Stevens - Johnson syndrome due to nevirapine. Namayanja GK; Nankya JM; Byamugisha JK; Ssali FN; Kityo CM; Rwambuya SD; Mugerwa RD; Mmiro FA; Morrison CS; Salata RA Afr Health Sci; 2005 Dec; 5(4):338-40. PubMed ID: 16615847 [TBL] [Abstract][Full Text] [Related]
16. A pharmacogenetics study in Mozambican patients treated with nevirapine: full resequencing of TRAF3IP2 gene shows a novel association with SJS/TEN susceptibility. Ciccacci C; Rufini S; Mancinelli S; Buonomo E; Giardina E; Scarcella P; Marazzi MC; Novelli G; Palombi L; Borgiani P Int J Mol Sci; 2015 Mar; 16(3):5830-8. PubMed ID: 25775161 [TBL] [Abstract][Full Text] [Related]
17. Association between CYP2B6 polymorphisms and Nevirapine-induced SJS/TEN: a pharmacogenetics study. Ciccacci C; Di Fusco D; Marazzi MC; Zimba I; Erba F; Novelli G; Palombi L; Borgiani P; Liotta G Eur J Clin Pharmacol; 2013 Nov; 69(11):1909-16. PubMed ID: 23774940 [TBL] [Abstract][Full Text] [Related]